InvestorsHub Logo
Followers 12
Posts 3841
Boards Moderated 0
Alias Born 04/30/2004

Re: None

Wednesday, 12/08/2021 11:31:07 AM

Wednesday, December 08, 2021 11:31:07 AM

Post# of 572
WOW

Aptose Biosciences (APTO) Receives a Buy from JonesTrading

Source: TipRanks
In a report issued on November 4, Soumit Roy from JonesTrading reiterated a Buy rating on Aptose Biosciences (APTO – Research Report), with a price target of $14.00. The company's shares closed last Friday at $2.00, close to its 52-week low of $1.97. According to TipRanks.com, Roy is a 5-star analyst with an average return of 20.9% and a 35.1% success rate. Roy covers the Healthcare sector, focusing on stocks such as Deciphera Pharmaceuticals, Adaptimmune Therapeutics, and Actinium Pharmaceuticals. Currently, the analyst consensus on Aptose Biosciences is a Moderate Buy with an average price target of $12.46, representing a 493.3% upside. In a report issued on October 29, H.C.
https://www.tipranks.com/news/blurbs/aptose-biosciences-apto-receives-a-buy-from-jonestrading?utm_source=advfn.com&utm_medium=referral
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News